Overview
- The U.S. Department of Commerce and IBM signed a letter of intent this week that would channel $1 billion in CHIPS Act funds to a new company called Anderon while IBM commits a matching $1 billion in cash and assets.
- Anderon is planned as a dedicated 300mm wafer foundry in Albany, New York, built to make superconducting qubit wafers and the process design kits, wafer testing systems, and production tools needed for broader industry use.
- The deal leaves key items unresolved because the announcement is a letter of intent rather than a final contract, so the government stake, funding disbursement, construction timeline, and legal terms must still be negotiated and executed.
- Financial markets reacted strongly to the announcement with IBM shares jumping about 11–12 percent and adding roughly $26 billion to the company’s market value as investors priced in the strategic shift toward manufacturing.
- The initiative is part of a wider CHIPS and Science Act push to secure domestic quantum supply chains and create jobs, and it builds on IBM’s claim of more than 90 deployed quantum systems and its stated aim for a fault-tolerant system by 2029.